Urology Surgical Devices Market Size, Share, Growth, and Industry Analysis, By Type (Urology Endoscopes,Endovision Systems,Peripheral Instruments,Consumables and Accessories), By Application (Hospitals,Ambulatory Surgical Centres,Specialty Clinics), Regional Insights and Forecast to 2035

Urology Surgical Devices Market Overview

Global Urology Surgical Devices Market size is anticipated to be worth USD 12509.3 million in 2026, projected to reach USD 22824.76 million by 2035 at a 6.9% CAGR.

The Urology Surgical Devices Market is expanding steadily due to rising urinary disorders, kidney stone procedures, prostate treatments, and minimally invasive surgery demand. In 2025, more than 132 million people globally were affected by chronic urological conditions requiring clinical intervention. Over 19 million cystoscopy and ureteroscopy procedures were performed annually worldwide. Minimally invasive urology surgeries represented 61% of total surgical volume due to shorter recovery periods and lower complication rates. Hospitals increased procurement of flexible scopes by 18% during the year. Disposable accessories usage reached 47% of procedure volumes, reflecting infection control priorities. Robotic-assisted urology surgeries crossed 1.3 million procedures globally.

The United States is the leading country market for Urology Surgical Devices, supported by high procedure volumes and advanced hospital infrastructure. In 2025, more than 6.8 million urology procedures were conducted across the country. Kidney stone treatment cases exceeded 1.2 million annually, while benign prostatic hyperplasia interventions crossed 780,000 procedures. Minimally invasive techniques accounted for 73% of total urology surgeries in U.S. hospitals. More than 5,400 ambulatory surgical centers offered urology-related services. Robotic-assisted prostatectomy utilization reached 69% of prostate cancer surgeries. Disposable catheter and accessory demand rose 16% due to infection prevention protocols.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Rising minimally invasive adoption and higher procedure demand support market expansion, with growth influence measured at 64%.
• Major Market Restraint: High equipment cost and sterilization complexity remain barriers, affecting 42% of healthcare buyers.
• Emerging Trends: Single-use scopes and robotic platforms are accelerating innovation, with adoption momentum reaching 38%.
• Regional Leadership: North America leads global demand with an estimated market share of 39%.
• Competitive Landscape: Top five manufacturers collectively account for 57% of competitive market presence.
• Market Segmentation: Urology endoscopes remain the leading type segment with 34% total demand share.
• Recent Development: Product launches in imaging and disposable devices increased by 29%.

Urology Surgical Devices Market Latest Trends

The Urology Surgical Devices Market is witnessing rapid transformation through minimally invasive technologies, digital imaging, and disposable instrument adoption. In 2025, flexible endoscope usage accounted for 58% of hospital urology visualization procedures due to improved access and shorter patient recovery time. High-definition endovision systems were installed in 44% of newly upgraded operating rooms. Single-use ureteroscopes gained strong traction, representing 31% of total ureteroscopy device demand because they reduce reprocessing delays and contamination risks. Robotic-assisted urology surgeries crossed 1.3 million global procedures, with prostate and kidney interventions leading adoption.

Laser-based stone management systems also expanded significantly, as holmium and thulium laser procedures increased 22% during the year. Ambulatory surgical centers raised outpatient urology procedures by 19%, creating higher demand for compact mobile imaging towers and reusable hand instruments. Hospitals reported a 17% decline in average post-operative stay after minimally invasive treatments. Artificial intelligence-assisted imaging tools improved lesion detection efficiency by 14% in pilot programs. Digital integration is another major trend, with 36% of advanced systems now linked to electronic records and procedure analytics platforms. Sustainability goals encouraged a 12% increase in recyclable accessory procurement across large healthcare networks.

Urology Surgical Devices Market Dynamics

DRIVER

"Rising prevalence of kidney stones, prostate disorders, and preference for minimally invasive surgery."

The Urology Surgical Devices Market is growing strongly because urinary tract disorders and age-related urological diseases continue to increase worldwide. In 2025, more than 132 million patients required clinical treatment for chronic urological conditions. Kidney stone incidence rose sharply, with over 19 million annual treatment procedures globally. Benign prostatic hyperplasia affected nearly 210 million men aged above 50 years, creating sustained demand for resection and visualization tools. Minimally invasive surgeries represented 61% of urology interventions because they lower blood loss and shorten recovery periods. Hospitals using advanced endoscopic systems reported 18% faster procedure turnover. Robotic-assisted surgeries also improved precision, helping boost adoption across tertiary care centers.

RESTRAINT

"High capital cost of advanced systems and sterilization burden for reusable devices."

Many healthcare facilities delay purchases because advanced urology towers, robotic systems, and imaging units require significant investment. In 2025, nearly 42% of mid-sized hospitals cited budget constraints as the main procurement barrier. Flexible reusable scopes require frequent maintenance cycles, while repair costs increased 16% compared with the previous year. Sterilization turnaround time added 27 minutes per instrument cycle in busy surgical centers. Smaller clinics often prefer referrals instead of direct ownership due to operating cost pressure. In developing markets, import dependency impacted 33% of equipment tenders. These financial and workflow barriers slow adoption despite rising patient demand.

OPPORTUNITY

"Expansion of disposable scopes, outpatient surgery centers, and robotic-assisted interventions."

The strongest opportunity lies in single-use devices and ambulatory procedure growth. In 2025, disposable ureteroscope demand increased 31% as hospitals focused on infection control and faster scheduling. Ambulatory surgical centers expanded outpatient urology volumes by 19%, driving demand for compact visualization platforms and portable energy systems. Robotic-assisted prostate and kidney surgeries crossed 1.3 million procedures globally, creating opportunities for precision instruments and accessories. Emerging countries increased hospital modernization budgets, while training programs for endourology rose 21%. Vendors offering lower-cost digital towers and subscription servicing models are gaining traction. Preventive screening growth also supports future procedure volumes.

CHALLENGE

"Skilled surgeon shortages, product recalls, and reimbursement variability."

The market faces operational challenges linked to specialist availability and regulatory compliance. In 2025, over 28% of regional hospitals reported shortages of trained endourology surgeons or technicians. Complex devices require regular calibration and staff training, increasing implementation timelines. Product recalls involving imaging sensors or accessory defects affected procurement confidence in several markets. Reimbursement variability across countries influenced 24% of hospital purchasing decisions. Rural centers continue to face delayed access to advanced procedures, while maintenance wait times for imported devices exceeded 14 days in some regions. Balancing innovation, affordability, and trained workforce availability remains a core challenge.

Urology Surgical Devices Market Segmentation

Download FREE Sample to learn more about this report.

By Type

Urology Endoscopes: Urology Endoscopes are the largest product segment with 34% market share due to extensive use in cystoscopy, ureteroscopy, nephroscopy, and bladder diagnostics. In 2025, more than 21 million endoscopic urology procedures were performed globally. Flexible scopes represented 58% of total endoscope demand because they improve navigation in narrow anatomy and reduce patient trauma. Hospitals increased procurement of digital scopes by 17% to improve image clarity and procedure efficiency. Reusable endoscopes remain common in large hospitals, while single-use models are growing rapidly. Demand is strongest in North America and Europe where minimally invasive treatment volumes remain high.

Endovision Systems: Endovision Systems hold 26% of the Urology Surgical Devices Market and include camera heads, monitors, light sources, processors, and recording units. In 2025, nearly 44% of newly upgraded urology operating rooms installed high-definition endovision platforms. Digital imaging systems improved lesion visibility by 19% compared with legacy analog systems. Hospitals increasingly prefer integrated towers combining imaging and data capture. Three-dimensional visualization demand rose 11% in robotic and laparoscopic urology centers. Large academic hospitals remain the primary buyers due to complex surgery volumes. Growth is also supported by replacement cycles as older imaging systems exceed 7 years of service life.

Peripheral Instruments: Peripheral Instruments account for 22% market share and include guidewires, dilators, graspers, baskets, forceps, sheaths, and resection tools. These devices are essential in stone retrieval, tissue removal, access creation, and biopsy procedures. In 2025, more than 48 million disposable and reusable peripheral instruments were utilized in urology surgeries worldwide. Stone retrieval baskets alone represented 14% of accessory unit demand. Hospitals favor ergonomic instruments that reduce hand fatigue during long procedures. Procedure-specific kits shortened preparation time by 16 minutes in high-volume centers. Demand remains strong because these products are required in nearly every endoscopic intervention.

Consumables and Accessories: Consumables and Accessories represent 18% of total demand, supported by recurring purchase cycles and infection control protocols. This segment includes catheters, irrigation sets, seals, tubing, biopsy cups, sterile covers, and disposable scope components. In 2025, disposable accessories were used in 47% of global urology procedures. Catheter-related product consumption increased 13% with rising inpatient and outpatient procedure counts. Hospitals expanded use of single-use sterile packs to reduce turnaround delays and contamination risks. Bulk purchasing contracts are common among multi-hospital networks. This segment generates stable replacement demand because items require regular replenishment after each procedure.

By Application

Hospitals: Hospitals are the dominant application segment with 63% market share due to specialist availability, advanced operating rooms, and emergency care capacity. In 2025, hospitals performed more than 70% of robotic-assisted urology surgeries globally. Large tertiary centers handled complex prostate, kidney, and bladder procedures requiring integrated imaging systems. Average equipment utilization rates exceeded 78% in urban hospitals. Capital budgets support purchases of digital towers and reusable scopes. Training programs and multidisciplinary care also strengthen hospital leadership in this segment.

Ambulatory Surgical Centres: Ambulatory Surgical Centres account for 24% of the market as outpatient treatment demand rises. In 2025, same-day kidney stone and diagnostic procedures increased 19% across major healthcare systems. These centers prefer compact imaging units, fast-turnover instruments, and lower maintenance devices. Average patient stay remained below 10 hours for routine endoscopic interventions. Cost efficiency and shorter scheduling times attract both patients and payers. Disposable scopes are increasingly used to avoid sterilization bottlenecks. This segment is growing quickly in North America and developed Asia markets.

Specialty Clinics: Specialty Clinics hold 13% share and focus on diagnostics, follow-up cystoscopy, catheter management, fertility-linked urology care, and minor interventions. In 2025, more than 9 million clinic visits globally involved procedural urology services. Clinics favor portable endoscopy systems and low-footprint imaging equipment. Appointment turnaround improved 21% where digital scheduling and integrated diagnostics were deployed. Urban private clinics are strong buyers of mid-cost devices with service contracts. Although smaller in scale, this segment supports consistent recurring demand and referral-driven procedures.

Urology Surgical Devices Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America is the largest regional market with 39% share, led by the United States and Canada. In 2025, the region performed more than 8 million urology procedures including cystoscopy, ureteroscopy, prostate surgery, and stone management. The United States alone accounted for over 6.8 million procedures annually. Minimally invasive surgery penetration reached 73% across major hospitals, driving strong demand for flexible endoscopes and endovision systems. Robotic-assisted prostatectomy represented 69% of prostate cancer surgeries in the region. Hospitals upgraded 32% of legacy imaging towers with high-definition systems during replacement cycles. Ambulatory surgical centers expanded outpatient stone treatment by 18%, increasing demand for compact mobile devices. Canada continued investing in public hospital modernization, with procedure room upgrades rising 11%. Disposable accessory usage also climbed because infection prevention remained a priority. Strong reimbursement systems, specialist density, and rapid technology adoption keep North America in the leading position.

Europe

Europe holds 29% of the Urology Surgical Devices Market, supported by Germany, the United Kingdom, France, Italy, and Spain. In 2025, more than 6 million urology interventions were conducted across the region. Public hospitals accounted for 64% of total equipment purchases, especially for reusable scopes and imaging platforms. Flexible ureteroscopy procedures increased 17% due to higher kidney stone incidence. Germany remained a key center for laser lithotripsy and endoscopic prostate treatment, while the UK expanded day-case surgery programs. Robotic-assisted urology volumes rose 14% across Western Europe. Hospitals emphasized sterilization efficiency, resulting in 21% higher demand for advanced reprocessing systems. Eastern Europe showed steady procurement growth as tertiary centers modernized operating rooms. Europe benefits from structured referral systems, trained specialists, and high awareness of early diagnosis. Replacement demand for aging endoscopy fleets continues to support stable regional growth.

Asia-Pacific

Asia-Pacific accounts for 24% market share and represents the fastest expanding regional opportunity. China, Japan, India, South Korea, and Australia are the major contributors. In 2025, hospital capacity additions supported more than 7 million urology procedures across the region. China expanded tertiary hospital procurement of digital endoscopy systems by 23%. Japan maintained strong demand for minimally invasive prostate and bladder procedures due to its aging population. India recorded rising kidney stone treatment volumes, with private hospital procedures increasing 19%. Australia saw growth in outpatient surgical centers using portable visualization systems. Robotic-assisted surgeries increased 16% across advanced metropolitan hospitals. Price-sensitive markets continue to adopt mid-range systems and refurbished support equipment, while premium urban centers choose high-definition and AI-enabled platforms. Government insurance expansion and private healthcare investment are improving access, making Asia-Pacific a long-term growth engine.

Middle East & Africa

Middle East & Africa holds 8% of global demand and is progressing through specialty care expansion and hospital modernization. Saudi Arabia, United Arab Emirates, South Africa, and Egypt are key markets. In 2025, urology procedure volumes exceeded 2 million across the region. Gulf countries increased advanced endoscopy procurement by 26% through public hospital investment programs. Robotic surgery centers expanded in major cities, especially for prostate and kidney cases. South Africa led sub-Saharan demand with rising private hospital adoption of laser stone treatment systems. Import dependency remains high, influencing 37% of purchasing decisions. Training shortages persist, yet regional fellowship programs increased 12% during the year. Mobile clinics and referral centers improved patient access in underserved areas. Disposable accessories gained popularity because of infection control requirements. Continued infrastructure spending and specialist expansion are expected to strengthen long-term market potential.

List of Top Urology Surgical Devices Companies

• Olympus
• Boston Scientific
• Medtronic
• Teleflex
• Karl Storz
• Richard Wolf
• Coopersurgical
• Coloplast
• Conmed
• Stryker
• Cook Medical

List of Top Two Urology Surgical Companies with Highest Market Share

• Olympus – Holds 19% market share driven by strong leadership in rigid and flexible endoscopy systems, wide hospital installed base, and extensive global distribution.
• Boston Scientific – Holds 14% market share supported by stone management devices, ureteroscopy products, disposable accessories, and strong presence in minimally invasive urology procedures.

Investment Analysis and Opportunities

The Urology Surgical Devices Market continues to attract investment due to rising surgical volumes, aging populations, and demand for minimally invasive treatment. In 2025, hospital capital allocation for endoscopy and visualization systems increased 18% globally. Private equity interest remained strong in disposable scope technologies, laser stone treatment platforms, and robotic-assisted surgery tools. More than 46% of large hospitals prioritized operating room modernization projects involving digital urology equipment. Investors favor recurring consumable segments because procedure-linked replacement demand remains stable.

Opportunities are strongest in ambulatory surgical centers, where outpatient urology procedure volumes rose 19% during the year. Single-use ureteroscope demand increased 31%, creating room for new entrants with cost-efficient models. Asia-Pacific offers major expansion potential as hospital procurement programs accelerated in China and India. Training simulators and surgeon education platforms also gained attention, with adoption rising 15%. Companies offering bundled service contracts, AI imaging upgrades, and compact mobile systems are positioned for strong growth. Cross-border distribution partnerships remain a key route for market entry and scale.

New Product Development

New product development in the Urology Surgical Devices Market is focused on digital visualization, disposable platforms, robotic precision, and energy-based treatment systems. In 2025, over 29% of major launches involved single-use scopes designed to eliminate reprocessing delays and contamination risk. New flexible ureteroscopes improved deflection performance by 17% and enhanced image resolution significantly. Compact endovision towers with touchscreen control gained traction in outpatient centers.

Laser innovation also accelerated, with next-generation thulium fiber systems reducing stone fragmentation time by 21% in pilot procedures. Robotic-assisted instrument upgrades improved articulation range and surgeon control during prostate and kidney surgeries. Smart irrigation pumps and pressure monitoring systems reduced complication risks during endoscopic procedures. Around 24% of launches included cloud-connected data logging for procedure analytics and maintenance alerts. Manufacturers also introduced ergonomic hand instruments that reduced operator fatigue during long cases. Product pipelines remain active across imaging, access tools, and disposable accessory categories.

Five Recent Developments (2023-2025)

• Olympus expanded digital endoscopy portfolio in 2024 with improved imaging systems for advanced cystoscopy and ureteroscopy procedures.
• Boston Scientific introduced updated stone management devices in 2025 with faster retrieval efficiency and stronger flexibility.
• Medtronic increased robotic surgery integration efforts in 2024 targeting precision urology interventions.
• Karl Storz launched upgraded visualization towers in 2023 featuring higher-definition imaging and workflow controls.
• Cook Medical expanded urology access device offerings in 2025 with enhanced guidewire and sheath performance.

Report Coverage of Urology Surgical Devices Market

This report provides detailed analysis of the Urology Surgical Devices Market across product types, applications, regions, and competitive positioning. It covers Urology Endoscopes, Endovision Systems, Peripheral Instruments, and Consumables and Accessories with market share estimates and demand indicators. Application analysis includes Hospitals, Ambulatory Surgical Centres, and Specialty Clinics based on procedure volume, procurement trends, and facility capability. The study evaluates technology shifts such as robotic surgery, digital imaging, laser treatment, and disposable scope adoption.

Regional coverage includes North America, Europe, Asia-Pacific, and Middle East & Africa with country-level trends and healthcare infrastructure insights. Competitive benchmarking reviews leading manufacturers based on installed base, innovation pipeline, product breadth, and strategic expansion. The report also assesses investment patterns, replacement demand, surgeon training needs, and outpatient procedure growth. It is designed for manufacturers, distributors, investors, hospitals, procurement teams, and strategic planners seeking data-driven opportunities in the evolving urology surgical devices industry.